← Back
$VYGR All transactions

Voyager Therapeutics, Inc.

A

$ Value

$0

Shares

100,000

Price

$0

Filed

Jan 8

Insider

Name

Shiferman Gregory L.

Title

SVP and General Counsel

CIK

0002041689

Roles

Officer

Transaction Details

Transaction Date

2026-01-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

100,000

Footnotes

This stock option was granted pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. | The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.

Filing Info

Accession No.

0001104659-26-002225

Form Type

4

Issuer CIK

0001640266

Shiferman Gregory L.'s History

Date Ticker Type Value
2026-04-01 VYGR A $0
2026-01-06 VYGR A $0
2025-07-31 SAGE U
2025-07-31 SAGE D
2025-07-31 SAGE D
2025-07-31 SAGE D
2025-06-24 SAGE F $728

Other Insiders at VYGR (90d)

Insider Bought Sold Last
Sandrock Alfred
President and CEO
$184K 2026-04-02
Jorgensen Nathan D.
Chief Financial Officer
$18K 2026-02-24
Swartz Robin
COO & CBO
$55K 2026-02-24
Carter Todd Alfred
Chief Scientific Officer
$41K 2026-02-24
Ferguson Toby
Chief Medical Officer
2026-02-06
Shiferman Gregory L.
SVP and General Counsel
2026-04-01